Hazlett, Burt & Watson’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-35
Closed 860
2025
Q1
$0 Hold
35
﹤0.01% 834
2024
Q4
$0 Hold
35
﹤0.01% 777
2024
Q3
$0 Hold
35
﹤0.01% 749
2024
Q2
$0 Hold
35
﹤0.01% 728
2024
Q1
$1K Hold
35
﹤0.01% 692
2023
Q4
$1K Hold
35
﹤0.01% 670
2023
Q3
$1K Buy
+35
New +$817 ﹤0.01% 700
2023
Q1
Sell
-90
Closed -$2K 687
2022
Q4
$2K Hold
90
﹤0.01% 579
2022
Q3
$2K Buy
90
+55
+157% +$1.93K ﹤0.01% 583
2022
Q2
$1K Buy
+35
New +$1.49K ﹤0.01% 589

Other funds holding TDOC

Hazlett, Burt & Watson's TDOC Position: Q2 2025 in Review

Hazlett, Burt & Watson sold out of Teladoc Health (TDOC) in Q2 2025, closing a stake of 35 shares.

Hazlett, Burt & Watson first reported a position in TDOC in Q2 2022 and held it in 10 quarters. The position peaked at $2K in Q4 2022. 359 funds tracked by Wall St. Rank hold TDOC as of Q2 2025.

  • Hazlett, Burt & Watson reported no remaining Teladoc Health position as of Q2 2025 after selling out during the quarter.
  • Hazlett, Burt & Watson sold 35 Teladoc Health shares in Q2 2025.
  • Hazlett, Burt & Watson first reported a position in Teladoc Health in Q2 2022 and held it in 10 quarters.
  • Hazlett, Burt & Watson's Teladoc Health position peaked at $2K in Q4 2022.
  • 359 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2025.

Based on Hazlett, Burt & Watson's 13F filing for Q2 2025, filed 25 Jul 2025.